Joanne Tan
Senior Vice President, Research & Development Parvus Therapeutics
Joanne brings more than 15 years of industry experience building R&D teams and advancing drug candidates through development and clinical proof-of-concept studies. Prior to Parvus, Joanne served as Head of Translational Sciences at Nkarta and Sana Biotechnology and Head of Clinical Biomarker at Schrodinger. At Arcus Biosciences, Joanne served in a series of leadership rolesdeveloping biomarker strategies and advancing the pre-clinical pipeline. Joanne’s earlier experience includes Research and Development roles at Compugen, ChemoCentryx, and Genentech. Joanne earned her BSc with honors and PhD in Immunology and Developmental Biology from Trinity College at the University of Toronto.
Seminars
- Defining effective Treg modulation to develop a standardized measurement of efficacy beyond the number of Tregs
- Evaluating genomic screening, cytokine measurement, Treg biology and tissue samples to identify the most effective strategy to measure Treg efficacy
- Highlighting the endpoint and efficacy criteria required for regulatory approval
- Discussing the translatability of preclinical mouse model biomarkers to patients
